This study aimed to examine the relationship between myostatin levels and the vascular reactivity index (VRI)—a reliable and non-invasive indicator of endothelial function assessed using temperature-based digital monitoring—in patients with CKD stages 3–5 who are not receiving dialysis. This evidence concerns the gene MSTN and chronic kidney disease.